CELCUITY INC. - COMMON STOCK

Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences

21 May 2025 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

14 May 2025 13:01:00 By Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call

07 May 2025 04:05:00 By Nasdaq GlobeNewswire

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

01 Apr 2025 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

31 Mar 2025 13:01:00 By Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call 

24 Mar 2025 04:05:00 By Nasdaq GlobeNewswire

Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences

25 Feb 2025 04:05:00 By Nasdaq GlobeNewswire

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

11 Dec 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

14 Nov 2024 13:01:00 By Nasdaq GlobeNewswire

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

12 Nov 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

07 Nov 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

14 Aug 2024 13:01:00 By Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

07 Aug 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity To Participate in Jefferies Global Healthcare Conference

03 Jun 2024 13:01:00 By Nasdaq GlobeNewswire

Celcuity Announces Pricing of Underwritten Common Stock Offering

30 May 2024 04:36:22 By Nasdaq GlobeNewswire

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing

30 May 2024 04:00:01 By Nasdaq GlobeNewswire

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

15 May 2024 13:01:00 By Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

08 May 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

04 Apr 2024 04:05:00 By Nasdaq GlobeNewswire

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

27 Mar 2024 13:01:00 By Nasdaq GlobeNewswire